J&J is already a player in the market for drugs to treat resistant MDD with nasal spray antidepressant Spravato (esketamine ... cancer biotech IDRx and its KIT inhibitor for gastrointestinal ...

They may discuss switching to a different treatment besides Lamictal or Spravato. Your doctor can give you more information. Is it safe to use a nasal corticosteroid or decongestant during ...

In NYC, spring kicks off tree pollen season, followed by grass pollen in the summer and weed pollen in the late summer and ...

Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

A nasal spray developed to combat neuroinflammation has shown promise in treating traumatic brain injury (TBI) in mouse models. | Neuroscience ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...

He is the first patient to have permission from the U.S. Food and Drug Administration to try a nasal spray for moderate Alzheimer’s disease under the federal agency’s expanded access ...

Stella Mental Health Westmont is a top depression and anxiety clinic near Chicago that offers comprehensive mental health treatments like Spravato (esketamine) therapy, ketamine infusion, stellate ...

Payment options are available based on insurance coverage. The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 ...